Charlie Arntzen has worked tirelessly on new platforms to deliver drugs. He has focused on plant-based drug delivery systems, testing a wide range of plants as possible “manufacturing platforms” for therapeutics for the developing world. Now Arntzen, an Arizona State University…
Paradigm Kicks Off Genomic Profiling for Cancer Registry
Paradigm has announced they have initiated genomic testing for Pharmatech’s AccessPPM Cancer Registry. Pharmatech’s AccessPPM is a cancer registry designed to collect EMR data and genomic information to help best match cancer patients with targeted clinical trials. The AccessPPM program and…
Multiple Strains for Clinical Development to be tested with Cannabis Science
Cannabis Science Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announced that it has commenced production of multiple strains of cannabis and European Union certified hemp varieties to initiate scientific research to select the…
New Mouse Model May Open Autism Treatment Avenues
The hallmark of an excellent researcher is an open mind. That flexibility and openness is what led Nina Schor, the William H. Eilinger Chair of Pediatrics at the University of Rochester, to follow a hunch about a brain receptor– resulting in…
Los posibles medicamentos contra la gripe se centran en la respuesta inmunitaria
The seriousness of disease often results from the strength of the immune response, rather than with the virus, itself. Turning down that response, rather than attacking the virus, might be a better way to reduce that severity, said Juliet Morrison of…
New Brain Protein Tied to Alzheimer’s Disease
Scientists have linked a new protein to Alzheimer’s disease, different from the amyloid and tau that make up the sticky brain plaques and tangles long known to be its hallmarks. The discovery could give a new target for developing drugs and…
Research Shows Cannabis Compound Could Slow Tumor Growth
Scientists at the University of East Anglia have shown how the main psychoactive ingredient in cannabis could reduce tumor growth in cancer patients. Research reveals the existence of previously unknown signaling platforms which are responsible for the drug’s success in shrinking tumors….
Governor Pushes for Trials of Marijuana Derivative
Georgia’s governor is pushing clinical trials for a marijuana-derived drug that proponents say could help treat severe seizure disorders among children, an unlikely election-year move for a Republican in a conservative part of the country that is just beginning to warm…
Study Says 99% of Alzheimer’s Drug Trials Fail
Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer’s disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing…
FDA Approves Inhalable Diabetes Drug Afrezza
The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals. The FDA cleared MannKind Corp.’s Afrezza, a fast-acting form of insulin for mealtime use, for adults with the…